We examined DNA repair-related pathways and tumor mutational burden (TMB) because homologous recombination deficiency (HRD) is linked to elevated immune activity31, and higher tumor mutational burden (TMB) is also associated with improved survival and increased CD8+ T-cell infiltration in ovarian cancer32. This evidence concerns the gene CD8A and hypoparathyroidism-retardation-dysmorphism syndrome.